story of the week
Management Strategies for Hypogammaglobulinemia Secondary to B-Cell–Depleting Therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis Journal - Experimental, Translational and Clinical
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Hypogammaglobulinemia secondary to B-cell depleting therapies in neuroimmunology: Comparing management strategies
Mult Scler J Exp Transl Clin 2023 Jul 01;9(2)20552173231182534, H Kelly, A Vishnevetsky, LB Chibnik, M LevyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.